Humanities
Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Effects of the ketogenic diet on multiple sclerosis with a focus on the paediatric population
  • Home
  • /
  • Effects of the ketogenic diet on multiple sclerosis with a focus on the paediatric population
  1. Home /
  2. Archives /
  3. Vol. 25 No. 1 (2023) /
  4. Articles

Effects of the ketogenic diet on multiple sclerosis with a focus on the paediatric population

Authors

  • Patrycja Szponarowicz 1 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej w Lublinie https://orcid.org/0009-0002-1403-8379
  • Przemysław Raczkiewicz Students’ Scientific Association at the Chair and Department of General and Pediatric Ophthalmology, Medical University of Lublin, 20-079 Lublin, Poland https://orcid.org/0000-0002-4986-4833
  • Mateusz Rzeszutko Samodzielny Publiczny Szpital Wojewódzki im. Jana Pawła II w Zamościu https://orcid.org/0009-0004-1368-551X
  • Bartosz Snopkowski 1 WOJSKOWY SZPITAL KLINICZNY Z POLIKLINIKĄ SAMODZIELNY PUBLICZNY ZAKŁAD OPIEKI ZDROWOTNEJ W LUBLINIE https://orcid.org/0009-0003-2800-592X
  • Eliasz Panek Wojewódzki Szpital Specjalistyczny im. Stefana Kardynała Wyszyńskiego w Lublinie https://orcid.org/0009-0001-3291-8188
  • Damian Jasłowski WOJEWÓDZKI SZPITAL SPECJALISTYCZNY im. Stefana Kardynała Wyszyńskiego Samodzielny Publiczny Zakład Opieki Zdrowotnej w Lublinie https://orcid.org/0000-0003-1943-7213
  • Dominika Panasiuk 1 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ w Lublinie https://orcid.org/0000-0003-2899-2630
  • Tomasz Korzec Szpital Wojewódzki Im.Św.Łukasza Samodzielny Publiczny Zakład Opieki Zdrowotnej w Tarnowie. https://orcid.org/0000-0002-9396-951X
  • Jakub Sosnowski 1 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej w Lublinie https://orcid.org/0009-0009-5590-9653
  • Mateusz Skrętowicz 1 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej w Lublinie https://orcid.org/0009-0009-8889-4718

DOI:

https://doi.org/10.12775/JEHS.2023.25.01.005

Keywords

multiple sclerosis, MS, ketogenic diet, pediatric multiple sclerosis, diet

Abstract

Introduction and Purpose:

Multiple sclerosis (MS) is an autoimmune disease that damages the nervous system. Although MS is usually diagnosed in adults, it can also occur in children and adolescents, which presents diagnostic and therapeutic challenges. In recent years, attention has been drawn to the role of diet in alleviating MS symptoms, including in the pediatric population. The ketogenic diet, characterized by low carbohydrate intake, high fat intake, and moderate protein intake, is of interest as an additional therapeutic approach in MS due to its effects on metabolism and reduction of inflammation in the body.

 

Materials and methods:

This article reviews the literature on the impact of the ketogenic diet on MS, with particular emphasis on its impact on the course of MS in the pediatric population. Articles were searched by key words, e.g. multiple sclerosis, paediatrics, children, diet, ketogenic diet, in various configurations, in Scopus, Medline, Google Scholar databases.

 

Current state of knowledge:

While there are several studies on the effects of the ketogenic diet, including those on MS in children, the results are inconclusive and require further research. Some publications suggest that the ketogenic diet can help alleviate MS symptoms, such as problems with balance and coordination, and improve patients' quality of life.

 

Conclusions:

In conclusion, the ketogenic diet may be a promising approach in the treatment of pediatric MS, but requires further research and careful assessment of benefits and risks before its introduction into therapy.

References

Ad S, Gc E. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci J Can Sci Neurol. 1993;20(1). doi:10.1017/s0317167100047351

Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343(13):938-952. doi:10.1056/NEJM200009283431307

Compston A, Coles A. Multiple sclerosis. The Lancet. 2002;359(9313):1221-1231. doi:10.1016/S0140-6736(02)08220-X

Loma I, Heyman R. Multiple Sclerosis: Pathogenesis and Treatment. Curr Neuropharmacol. 2011;9(3):409. doi:10.2174/157015911796557911

McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121-127. doi:10.1002/ana.1032

Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997;120(11):2059-2069. doi:10.1093/brain/120.11.2059

Fangerau T, Schimrigk S, Haupts M, et al. Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria. Acta Neurol Scand. 2004;109(6):385-389. doi:10.1111/j.1600-0404.2004.00246.x

Gitto L. Living with Multiple Sclerosis in Europe: Pharmacological Treatments, Cost of Illness, and Health-Related Quality of Life Across Countries. In: Zagon IS, McLaughlin PJ, eds. Multiple Sclerosis: Perspectives in Treatment and Pathogenesis. Codon Publications; 2017. Accessed March 6, 2023. http://www.ncbi.nlm.nih.gov/books/NBK470141/

Pugliatti M, Rosati G, Carton H, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol. 2006;13(7):700-722. doi:10.1111/j.1468-1331.2006.01342.x

Brenton JN, Kammeyer R, Gluck L, Schreiner T, Makhani N. Multiple Sclerosis in Children: Current and Emerging Concepts. Semin Neurol. 2020;40(2):192-200. doi:10.1055/s-0040-1703000

Epidemiology of Pediatric-Onset Multiple Sclerosis: A Systematic Review of the Literature - Anna Jeong, Denise M. Oleske, Joan Holman, 2019. Accessed March 7, 2023. https://journals.sagepub.com/doi/10.1177/0883073819845827

Yan K, Balijepalli C, Desai K, Gullapalli L, Druyts E. Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis. Mult Scler Relat Disord. 2020;44. doi:10.1016/j.msard.2020.102260

Brenton JN, Piccio L. Strengthening the link: Diet quality and disability in MS. Mult Scler J. 2023;29(2):157-159. doi:10.1177/13524585221127413

Jf C, Kj O, K S, V P, Tg D. The gut microbiome in neurological disorders. Lancet Neurol. 2020;19(2). doi:10.1016/S1474-4422(19)30356-4

Bhargava P, Anthony DC. Metabolomics in multiple sclerosis disease course and progression. Mult Scler Houndmills Basingstoke Engl. 2020;26(5):591-598. doi:10.1177/1352458519876020

Brenton JN, Goldman MD. A study of dietary modification: Perceptions and attitudes of patients with multiple sclerosis. Mult Scler Relat Disord. 2016;8:54-57. doi:10.1016/j.msard.2016.04.009

Lim JM, Letchumanan V, Tan LTH, et al. Ketogenic Diet: A Dietary Intervention via Gut Microbiome Modulation for the Treatment of Neurological and Nutritional Disorders (a Narrative Review). Nutrients. 2022;14(17):3566. doi:10.3390/nu14173566

Kirkpatrick CF, Bolick JP, Kris-Etherton PM, et al. Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force. J Clin Lipidol. 2019;13(5):689-711.e1. doi:10.1016/j.jacl.2019.08.003

Bough KJ, Wetherington J, Hassel B, et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol. 2006;60(2):223-235. doi:10.1002/ana.20899

Benson LA, Healy BC, Gorman MP, et al. Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years. Mult Scler Relat Disord. 2014;3(2):186-193. doi:10.1016/j.msard.2013.06.004

Mp G, Bc H, M PT, T C. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol. 2009;66(1). doi:10.1001/archneurol.2008.505

Ghassemi R, Narayanan S, Banwell B, et al. Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis. PloS One. 2014;9(2):e85741. doi:10.1371/journal.pone.0085741

B B, A BO, Dl A, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol. 2011;10(5). doi:10.1016/S1474-4422(11)70045-X

Lavery AM, Collins BN, Waldman AT, et al. The contribution of secondhand tobacco smoke exposure to pediatric multiple sclerosis risk. Mult Scler Houndmills Basingstoke Engl. 2019;25(4):515-522. doi:10.1177/1352458518757089

Graves JS, Chitnis T, Weinstock-Guttman B, et al. Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis. Pediatrics. 2017;139(4):e20162838. doi:10.1542/peds.2016-2838

Huppke B, Ellenberger D, Rosewich H, Friede T, Gärtner J, Huppke P. Clinical presentation of pediatric multiple sclerosis before puberty. Eur J Neurol. 2014;21(3):441-446. doi:10.1111/ene.12327

Ahn JJ, O’Mahony J, Moshkova M, et al. Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice. Mult Scler Houndmills Basingstoke Engl. 2015;21(6):735-748. doi:10.1177/1352458514551453

Chitnis T, Graves J, Weinstock-Guttman B, et al. Distinct effects of obesity and puberty on risk and age at onset of pediatric MS. Ann Clin Transl Neurol. 2016;3(12):897-907. doi:10.1002/acn3.365

Langer-Gould A, Brara SM, Beaber BE, Koebnick C. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology. 2013;80(6):548-552. doi:10.1212/WNL.0b013e31828154f3

Aj T, Bl B, F B, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2). doi:10.1016/S1474-4422(17)30470-2

Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler J. 2013;19(10):1261-1267. doi:10.1177/1352458513484547

Balint B, Haas J, Schwarz A, et al. T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients. Neurology. 2013;81(9):784-792. doi:10.1212/WNL.0b013e3182a2ce0e

Vargas-Lowy D, Kivisäkk P, Gandhi R, et al. Increased Th17 response to myelin peptides in pediatric MS. Clin Immunol Orlando Fla. 2013;146(3):176-184. doi:10.1016/j.clim.2012.12.008

Cala CM, Moseley CE, Steele C, et al. T cell cytokine signatures: biomarkers in pediatric multiple sclerosis. J Neuroimmunol. 2016;297:1-8. doi:10.1016/j.jneuroim.2016.04.015

Kraus V, Srivastava R, Kalluri SR, et al. Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease. Neurology. 2014;82(6):470-473. doi:10.1212/WNL.0000000000000097

Jakimovski D, Awan S, Eckert SP, Farooq O, Weinstock-Guttman B. Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment. CNS Drugs. 2022;36(1):45-59. doi:10.1007/s40263-021-00887-w

McKay KA, Friberg E, Razaz N, Alexanderson K, Hillert J. Long-term Socioeconomic Outcomes Associated With Pediatric-Onset Multiple Sclerosis. JAMA Neurol. 2021;78(4):478-482. doi:10.1001/jamaneurol.2020.5520

Puchalska P, Crawford PA. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell Metab. 2017;25(2):262-284. doi:10.1016/j.cmet.2016.12.022

Williams MS, Turos E. The Chemistry of the Ketogenic Diet: Updates and Opportunities in Organic Synthesis. Int J Mol Sci. 2021;22(10):5230. doi:10.3390/ijms22105230

Alharbi A, Al-Sowayan NS. The Effect of Ketogenic-Diet on Health. Food Nutr Sci. 2020;11(4):301-313. doi:10.4236/fns.2020.114022

Steinhauser ML, Olenchock BA, O’Keefe J, et al. The circulating metabolome of human starvation. JCI Insight. 2018;3(16). doi:10.1172/jci.insight.121434

Valenzuela PL, Castillo-García A, Lucia A, Naclerio F. Effects of Combining a Ketogenic Diet with Resistance Training on Body Composition, Strength, and Mechanical Power in Trained Individuals: A Narrative Review. Nutrients. 2021;13(9):3083. doi:10.3390/nu13093083

Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67(8):789-796. doi:10.1038/ejcn.2013.116

Phinney SD, Bistrian BR, Wolfe RR, Blackburn GL. The human metabolic response to chronic ketosis without caloric restriction: Physical and biochemical adaptation. Metab - Clin Exp. 1983;32(8):757-768. doi:10.1016/0026-0495(83)90105-1

D D, K K, A P. The Role of Ketogenic Diet in the Treatment of Neurological Diseases. Nutrients. 2022;14(23). doi:10.3390/nu14235003

Kim DY, Hao J, Liu R, Turner G, Shi FD, Rho JM. Inflammation-Mediated Memory Dysfunction and Effects of a Ketogenic Diet in a Murine Model of Multiple Sclerosis. PLOS ONE. 2012;7(5):e35476. doi:10.1371/journal.pone.0035476

Choi IY, Piccio L, Childress P, et al. A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. Cell Rep. 2016;15(10):2136-2146. doi:10.1016/j.celrep.2016.05.009

D DM, F C, G A, et al. Ketogenic and Modified Mediterranean Diet as a Tool to Counteract Neuroinflammation in Multiple Sclerosis: Nutritional Suggestions. Nutrients. 2022;14(12). doi:10.3390/nu14122384

Vauzour D. Polyphenols and brain health. OCL. 2017;24(2):A202. doi:10.1051/ocl/2017008

M B, F S, F Z, S B. Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflammation. 2021;9(1). doi:10.1212/NXI.0000000000001102

Bock M, Karber M, Kuhn H. Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis. eBioMedicine. 2018;36:293-303. doi:10.1016/j.ebiom.2018.08.057

Brenton JN, Banwell B, Bergqvist AGC, et al. Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflammation. 2019;6(4):e565. doi:10.1212/NXI.0000000000000565

Brenton JN, Lehner-Gulotta D, Woolbright E, et al. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022;93(6):637-644. doi:10.1136/jnnp-2022-329074

Benlloch M, López-Rodríguez MM, Cuerda-Ballester M, et al. Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients. Nutrients. 2019;11(5):1156. doi:10.3390/nu11051156

Downloads

  • PDF

Published

2023-05-02

How to Cite

1.
SZPONAROWICZ, Patrycja, RACZKIEWICZ, Przemysław, RZESZUTKO, Mateusz, SNOPKOWSKI, Bartosz, PANEK, Eliasz, JASŁOWSKI, Damian, PANASIUK, Dominika, KORZEC, Tomasz, SOSNOWSKI, Jakub and SKRĘTOWICZ, Mateusz. Effects of the ketogenic diet on multiple sclerosis with a focus on the paediatric population. Journal of Education, Health and Sport. Online. 2 May 2023. Vol. 25, no. 1, pp. 57-65. [Accessed 1 July 2025]. DOI 10.12775/JEHS.2023.25.01.005.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 25 No. 1 (2023)

Section

Articles

License

Copyright (c) 2023 Patrycja Szponarowicz, Przemysław Raczkiewicz, Mateusz Rzeszutko, Bartosz Snopkowski, Eliasz Panek, Damian Jasłowski, Dominika Panasiuk, Tomasz Korzec, Jakub Sosnowski, Mateusz Skrętowicz

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 632
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

multiple sclerosis, MS, ketogenic diet, pediatric multiple sclerosis, diet
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop